Hypera SA Acquires Takeda's Portfolio Transcript
Good morning. Welcome to the Hypera Pharma conference call to discuss the recent transformational acquisitions made by the company. Mr. Ãlvaro Stainfeld, Chairman; Mr. Breno Oliveira, CEO; and Mr. Adalmario Couto, CFO and Business Development Officer, are currently here with us today.
(Operator Instructions)
This slide webcast is also broadcast at www.hypera.com.br/ir. We would like to inform that statements during this conference call may constitute forward-looking statements. Such statements are subjected to known and unknown risks and uncertainties that could cause the company's actual results to differ materially from those set forth in the forward-looking statements. I'll turn the floor over to Mr. Ãlvaro Stainfeld, who will begin his presentation. You have the floor now, Mr. Stainfeld.
Thank you. Good afternoon. I'm honored to announce on behalf of our Board of Directors with Breno and Adalmario, we are proudly announcing
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
